March 26th, 2024

Metastatic mesenchymal chondrosarcoma showing a sustained response to cabozantinib: A case report Veronika Blum, 1 , † Vanghelita Andrei, 2 , † Baptiste Ameline, 2 Silvia Hofer, 3 Bruno Fuchs, 1 Klaus Strobel, 1 Anna Allemann, 1 Beata Bode, 4…

March 3rd, 2024

Typically after surgery, it is important to know what post-surgical options are available. Making the decision to enroll in a clinical trial is one of those options and maybe one of the most important decisions chondrosarcoma patients and their…

February 25th, 2024

Genomic sequencing is a promising tool for expanding the treatment options for chondrosarcoma patients. Genomic sequencing technologies are capable of characterizing known and novel clinically relevant biomarkers, like IDH1/2, and is becoming a…

February 23rd, 2024

Daniel Brian Hurley, M.D. passed away August 3, 2023, from dedifferentiated chondrosarcoma at age 50 surrounded by his loved ones. His wife Traci and their three kids Rachel, Sam, and Sarah were the light of his life. His family, including his…

February 19th, 2024

Be Part of the First full Analysis of the Chondrosarcoma Patient Registry https://chondrosarcoma.iamrare.org

It is not too late to sign up to participate in the Chondrosarcoma Patient Registry. The Chondrosarcoma Foundation has been preparing to…

February 8th, 2024

Thank You!!!!

To Everyone that participated in Chondrosarcoma Awareness Day. It is wonderful to see people from all over the globe come together to honor our CS survivors and those who lost their battle to this terrible bone cancer. And it is great…

February 5th, 2024

Tomorrow, February 6 is Chondrsarcoma Awareness Day.

Join the Fight

Wear something Yellow.

Take a picture (family, friends, work colleagues) and post it to #cswecare #chondrosarcoma #chondrosarcomafoundation

Sign our Petition to support more…

February 2nd, 2024

This coming Tuesday, February 6 is Chondrsarcoma Awareness Day.

Join the Fight

Wear something Yellow.

Take a picture (family, friends, work colleagues) and post it to #cswecare #chondrosarcoma #chondrosarcomafoundation

Sign our Petition to…

February 1st, 2024

Preclinical Characterization and Phase I Trial Results
of INBRX-109, A Third-Generation, Recombinant,
Humanized, Death Receptor 5 Agonist Antibody,
in Chondrosarcoma
Vivek Subbiah1, Sant P. Chawla2, Anthony P. Conley3, Breelyn A. Wilky4, Anthony…

January 29th, 2024

Sixth Tribute for Chondrosarcoma Awareness Day

NIne Days away from hosting Chondrosarcoma Awareness Day on February 6 (Shayna’s heavenly 33rd birthday). This is our international effort to educate the public about this rare bone cancer and to…